We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1109:HKEXChina Resources Land Limited Analysis

Data as of 2026-03-14 - not real-time

HK$30.08

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

China Resources Land (1109.HK) trades around HK$30, well below its industry‑average PE of 32.5 and with a price‑to‑book of 0.68, indicating a deep value opportunity. The company delivers a robust 4.79% dividend yield on a modest 34% payout ratio, backed by strong operating cash flow and a solid balance sheet, suggesting the dividend is sustainable. Revenue is growing at roughly 20% YoY and margins remain healthy, reinforcing the case for a blend of growth and value appeal.
Technically, the stock sits just under its 20‑day SMA and the MACD has turned bearish, while volume is increasing and a clear support level sits near HK$29.1. Volatility is elevated at 34% over the past month, but the low beta (~0.17) points to limited systematic risk. Overall, the fundamentals are compelling, the valuation appears attractive, and the dividend adds a defensive cushion, making the stock a candidate for accumulation despite short‑term technical softness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above key support at HK$29.1
  • Bearish MACD signal suggesting limited upside in the near term
  • High dividend yield providing downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap vs industry (PE 6.9 vs 32.5)
  • Strong cash generation and low debt‑to‑equity relative to peers
  • Analyst consensus target median price around HK$36, implying ~20% upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend policy with low payout ratio
  • Continued urbanisation‑driven demand for residential and commercial assets in China
  • Low systematic risk (beta ~0.17) and solid balance sheet for resilience

Key Metrics & Analysis

Financial Health

Revenue Growth19.90%
Profit Margin9.25%
P/E Ratio6.9
ROE8.91%
ROA2.72%
Debt/Equity82.83
P/B Ratio0.7
Op. Cash FlowHK$28.0B
Free Cash FlowHK$11.1B
Industry P/E32.5

Technical Analysis

TrendBullish
RSI44.0
SupportHK$29.12
ResistanceHK$33.76
MA 20HK$31.13
MA 50HK$30.21
MA 200HK$29.41
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueHK$17.79
Target PriceHK$37.86
Upside/Downside25.87%
GradeUndervalued
TypeBlend
Dividend Yield4.79%

Risk Assessment

Beta0.17
Volatility34.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.